Zhibin Cui

567 total citations
15 papers, 355 citations indexed

About

Zhibin Cui is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Zhibin Cui has authored 15 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Immunology. Recurrent topics in Zhibin Cui's work include interferon and immune responses (3 papers), RNA modifications and cancer (3 papers) and Epigenetics and DNA Methylation (2 papers). Zhibin Cui is often cited by papers focused on interferon and immune responses (3 papers), RNA modifications and cancer (3 papers) and Epigenetics and DNA Methylation (2 papers). Zhibin Cui collaborates with scholars based in United States, China and Taiwan. Zhibin Cui's co-authors include Li Mao, Wei Cao, Yifan Han, Wei-Hsuan Hsu, Wantao Chen, Jiang Li, Wantao Chen, Zhien Feng, Guangjun Zhang and Chenping Zhang and has published in prestigious journals such as PLoS ONE, Cancer Cell and Cancer.

In The Last Decade

Zhibin Cui

15 papers receiving 352 citations

Peers

Zhibin Cui

ONCOL

IMMUN

PFM

Mohsen Karami Fath Iran

Haojun Xu China

Francesca R. Dejure Germany

Nurmaa K. Dashzeveg Japan

Lara Vecchi Brazil

Keun Young Kim South Korea

Bodvaël Pennarun Netherlands

Sandra Koseoglu United States

Medine Cansoy Netherlands

Shurui Cai United States

Mohsen Karami Fath Iran

Zhibin Cui

338 ×1.4

159 ×1.8

105 ×1.8

ONCOL

61 ×1.1

IMMUN

26 ×0.8

PFM

Citations per year, relative to Zhibin Cui Zhibin Cui (= 1×) peers Mohsen Karami Fath

Countries citing papers authored by Zhibin Cui

Since Specialization

Citations

This map shows the geographic impact of Zhibin Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhibin Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhibin Cui more than expected).

Fields of papers citing papers by Zhibin Cui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhibin Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhibin Cui. The network helps show where Zhibin Cui may publish in the future.

Co-authorship network of co-authors of Zhibin Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Zhibin Cui. A scholar is included among the top collaborators of Zhibin Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhibin Cui. Zhibin Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Na’ara, Shorook, Zhibin Cui, Becky Xu Hua Fu, et al.. (2025). Neddylation as a target in PIK3CA-mutated head and neck cancer. Biochemical and Biophysical Research Communications. 759. 151703–151703. 1 indexed citations

Grandis, Jennifer R., Katherine A. Skorupski, Ning Cheng, et al.. (2025). Safety and efficacy of a STAT3-targeted cyclic oligonucleotide: From murine models to a phase 1 clinical trial in pet cats with oral cancer. Cancer Cell. 43(11). 2051–2068.e9. 2 indexed citations

Johnson, Daniel E. & Zhibin Cui. (2025). Triggering Pyroptosis in Cancer. Biomolecules. 15(3). 348–348. 2 indexed citations

Cui, Zhibin, et al.. (2021). Caspase-8 mutations associated with head and neck cancer differentially retain functional properties related to TRAIL-induced apoptosis and cytokine induction. Cell Death and Disease. 12(8). 775–775. 17 indexed citations

Mohammed, Sulma I., Sagar M. Utturkar, Maxwell Lee, et al.. (2020). Ductal Carcinoma In Situ Progression in Dog Model of Breast Cancer. Cancers. 12(2). 418–418. 17 indexed citations

Mani, Saravana Kumar Kailasam, Bingyu Yan, Zhibin Cui, et al.. (2020). Restoration of RNA helicase DDX5 suppresses hepatitis B virus (HBV) biosynthesis and Wnt signaling in HBV-related hepatocellular carcinoma. Theranostics. 10(24). 10957–10972. 38 indexed citations

Cui, Zhibin, Hyunseok Kang, Jennifer R. Grandis, & Daniel E. Johnson. (2020). CYLD Alterations in the Tumorigenesis and Progression of Human Papillomavirus–Associated Head and Neck Cancers. Molecular Cancer Research. 19(1). 14–24. 18 indexed citations

Cui, Zhibin, et al.. (2017). KANK1 inhibits cell growth by inducing apoptosis through regulating CXXC5 in human malignant peripheral nerve sheath tumors. Scientific Reports. 7(1). 40325–40325. 29 indexed citations

Cui, Zhibin, et al.. (2016). Evolutionary and developmental analysis reveals KANK genes were co-opted for vertebrate vascular development. Scientific Reports. 6(1). 27816–27816. 17 indexed citations

10.

Han, Yifan, et al.. (2016). Miracle Fruit (Synsepalum dulcificum) Exhibits as a Novel Anti-Hyperuricaemia Agent. Molecules. 21(2). 140–140. 28 indexed citations

11.

Cui, Zhibin, Liwei Song, Zhaoyuan Hou, et al.. (2015). PLU-1/JARID1B overexpression predicts proliferation properties in head and neck squamous cell carcinoma. Oncology Reports. 33(5). 2454–2460. 13 indexed citations

12.

Han, Yifan, et al.. (2015). In Vitro and in Vivo Anticancer Activity of Pardaxin against Proliferation and Growth of Oral Squamous Cell Carcinoma. Marine Drugs. 14(1). 2–2. 51 indexed citations

13.

Zhang, Guangjun, Jer‐Yen Yang, & Zhibin Cui. (2014). New Insight into Cancer Aneuploidy in Zebrafish. International review of cell and molecular biology. 314. 149–170. 1 indexed citations

14.

Cui, Zhibin, et al.. (2013). TRIM24 Overexpression Is Common in Locally Advanced Head and Neck Squamous Cell Carcinoma and Correlates with Aggressive Malignant Phenotypes. PLoS ONE. 8(5). e63887–e63887. 58 indexed citations

15.

Cao, Wei, Zhien Feng, Zhibin Cui, et al.. (2011). Up‐regulation of enhancer of zeste homolog 2 is associated positively with cyclin D1 overexpression and poor clinical outcome in head and neck squamous cell carcinoma. Cancer. 118(11). 2858–2871. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact